semaglutide alcohol craving Many patients taking GLP-1 medications like Ozempic and Wegovy say they notice something unexpected: less interest in alcohol. Now, new research suggests there may be a reason why. A recent study found Semaglutide shows promise in reducing

Moreover, the interpretation of biomarker responses is complicated by the poor bioavailability and limited bloodbrain barrier penetration of many phytochemicals

Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes

The primary composition-of-matter patent expired in 2028 in the U.S

It would be exciting to see if they are involved in redox regulation of virulence regulators as seen in B

If a patient regains more than 5% of body weight before reaching the zero-dose step, that signals the need to pause the taper, reassess behavioral supports, and consider whether full discontinuation is the right goal